BPTH On Steady Path, CGIX On Watch, GLPG/GILD Scrap IPF Drug, REGN’s Libtayo Gets FDA Nod

(RTTNews) – Today’s Daily Dose brings you news about Bio-Path’s patented DNAbilize platform technology, Cancer Genetics’ stock offering, Galapagos/Gilead scrapping Ziritaxestat and FDA approving the expanded approval of Regeneron’s Libtayo.Read on…Read MoreMarketsMarkets Feed